Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Due Diligence
Comparison
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Capsaicin patch

LTS Lohmann Therapie-Systeme AG
Capsaicin, the active ingredient found in red-hot peppers, is used mainly for the relief of chronic pain of rheumatoid arthritis and osteoarthritis

Full description

Capsaicin, the active ingredient found in red-hot peppers, is used mainly for the relief of chronic pain of rheumatoid arthritis and osteoarthritis. Project status: The capsaicin patch developed by LTS is a flexible, rectangular patch with rounded corners with maximal surface area of 300 cm2 (smaller patches are possible) Due to its textile backing layer, the patch is one-way stretchable. It consists of a self adhesive matrix, containing capsaicin, below 0.5% in concentration, and exhibits a pleasant heat sensation and good adhesion. The intensity of the heat sensation can be varied in either direction by changing the capsaicin concentration The current formulation was tested for stability over 3 years indicating a stable patch formulation at room temperature. Competitive advantage: The main advantages of a topical capsaicin patch compared with available products on the market such as ointments or creams are: (1) application period (once per day), (2) avoidance of direct contact with the capsaicin (a solid matrix containing capsaicin), and (3) easy handling (pre-determined application area).

Development status

Phase I/II

Type of business relationship sought

Available for licensing. LTS will perform further development in collaboration with a partner. Further activities in the development of the patch include scale up to pilot plan production, validation and if required a clinical study in humans
Research Partnership for Due Diligence Execution
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us